Extremely significant positive changes in Collegium Pharmaceutical Inc (NASDAQ: COLL) investment behavior have recently occurred: positive upside/downside volume developed, the stock’s recent price rise disrupted its longer term downtrend, and the stock rose on very heavy volume.
Recent notable positive changes in fundamentals have benefitted Collegium Pharmaceutical Inc (NASDAQ: COLL): significant quarterly earnings acceleration occurred, and the stock’s power rating rose above 70.
In light of these very positive signals we are reviewing our current Overall Rating of A. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
COLL is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Collegium Pharmaceutical has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Collegium Pharmaceutical has a good Power Rating of 77 and a very high Appreciation Score of 98, with the Highest Value Trend Rating the result.
Recent Price Action
Collegium Pharmaceutical Inc (NASDAQ: COLL) stock closed at $33.86 on 1/3/24 after a very large increase of 8.4%. Moreover, trading volume in this advance was exceptionally high at 450% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 12.7% during the last week.
Be the first to comment